Capitol Health Limited (ASX: CAJ)
Australia
· Delayed Price · Currency is AUD
0.375
+0.020 (5.63%)
Dec 3, 2024, 4:10 PM AEST
Capitol Health Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
Operating Revenue | 234.82 | 234.82 | 209.59 | 184.16 | 178 | 153.79 | Upgrade
|
Revenue | 234.82 | 234.82 | 209.59 | 184.16 | 178 | 153.79 | Upgrade
|
Revenue Growth (YoY) | 12.03% | 12.03% | 13.81% | 3.46% | 15.74% | 3.05% | Upgrade
|
Cost of Revenue | 178.96 | 178.96 | 162.89 | 138.29 | 131.59 | 118.72 | Upgrade
|
Gross Profit | 55.86 | 55.86 | 46.71 | 45.87 | 46.41 | 35.08 | Upgrade
|
Selling, General & Admin | 6.57 | 6.57 | 6.52 | 4.74 | 4.99 | 4.32 | Upgrade
|
Operating Expenses | 33.63 | 33.63 | 31.4 | 25.8 | 26.38 | 24.44 | Upgrade
|
Operating Income | 22.22 | 22.22 | 15.3 | 20.07 | 20.03 | 10.63 | Upgrade
|
Interest Expense | -7.85 | -7.85 | -5.35 | -2.94 | -3.39 | -3.78 | Upgrade
|
Interest & Investment Income | 0.47 | 0.47 | 0.29 | 0.03 | 0.01 | 0.03 | Upgrade
|
Currency Exchange Gain (Loss) | -0.06 | -0.06 | 0.35 | 1.78 | -1.88 | 0.34 | Upgrade
|
Other Non Operating Income (Expenses) | -20.65 | -20.65 | 0.29 | 0.13 | 0.07 | -0.09 | Upgrade
|
EBT Excluding Unusual Items | -5.87 | -5.87 | 10.89 | 19.07 | 14.84 | 7.14 | Upgrade
|
Gain (Loss) on Sale of Investments | -0.57 | -0.57 | -17.58 | -2.12 | -0.73 | -1.62 | Upgrade
|
Asset Writedown | -2.26 | -2.26 | -2.09 | - | - | -5.9 | Upgrade
|
Other Unusual Items | -2.8 | -2.8 | -1.62 | -1 | 5.33 | 2.55 | Upgrade
|
Pretax Income | -11.5 | -11.5 | -10.39 | 15.95 | 19.44 | 2.16 | Upgrade
|
Income Tax Expense | 3.26 | 3.26 | 1.2 | 4.98 | 7.41 | 1.08 | Upgrade
|
Earnings From Continuing Operations | -14.76 | -14.76 | -11.59 | 10.97 | 12.03 | 1.09 | Upgrade
|
Net Income to Company | -14.76 | -14.76 | -11.59 | 10.97 | 12.03 | 1.09 | Upgrade
|
Minority Interest in Earnings | -0.09 | -0.09 | -0.12 | -0.24 | -0.11 | -0.22 | Upgrade
|
Net Income | -14.85 | -14.85 | -11.71 | 10.73 | 11.92 | 0.87 | Upgrade
|
Net Income to Common | -14.85 | -14.85 | -11.71 | 10.73 | 11.92 | 0.87 | Upgrade
|
Net Income Growth | - | - | - | -9.96% | 1277.92% | -96.44% | Upgrade
|
Shares Outstanding (Basic) | 1,063 | 1,063 | 1,054 | 1,036 | 1,020 | 814 | Upgrade
|
Shares Outstanding (Diluted) | 1,063 | 1,063 | 1,054 | 1,060 | 1,053 | 847 | Upgrade
|
Shares Change (YoY) | 0.90% | 0.90% | -0.61% | 0.68% | 24.26% | 3.08% | Upgrade
|
EPS (Basic) | -0.01 | -0.01 | -0.01 | 0.01 | 0.01 | 0.00 | Upgrade
|
EPS (Diluted) | -0.01 | -0.01 | -0.01 | 0.01 | 0.01 | 0.00 | Upgrade
|
EPS Growth | - | - | - | -10.63% | 1031.13% | -96.61% | Upgrade
|
Free Cash Flow | 18.49 | 18.49 | 20.52 | 18.69 | 32.67 | 22.84 | Upgrade
|
Free Cash Flow Per Share | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | Upgrade
|
Dividend Per Share | 0.009 | 0.009 | 0.010 | 0.010 | 0.010 | 0.010 | Upgrade
|
Dividend Growth | -10.13% | -10.13% | 0% | 0% | 0% | 0% | Upgrade
|
Gross Margin | 23.79% | 23.79% | 22.28% | 24.91% | 26.07% | 22.81% | Upgrade
|
Operating Margin | 9.46% | 9.46% | 7.30% | 10.90% | 11.25% | 6.91% | Upgrade
|
Profit Margin | -6.33% | -6.33% | -5.59% | 5.83% | 6.70% | 0.56% | Upgrade
|
Free Cash Flow Margin | 7.87% | 7.87% | 9.79% | 10.15% | 18.36% | 14.85% | Upgrade
|
EBITDA | 36.81 | 36.81 | 28.21 | 30.4 | 32.13 | 22.21 | Upgrade
|
EBITDA Margin | 15.68% | 15.68% | 13.46% | 16.51% | 18.05% | 14.44% | Upgrade
|
D&A For EBITDA | 14.59 | 14.59 | 12.91 | 10.34 | 12.11 | 11.58 | Upgrade
|
EBIT | 22.22 | 22.22 | 15.3 | 20.07 | 20.03 | 10.63 | Upgrade
|
EBIT Margin | 9.46% | 9.46% | 7.30% | 10.90% | 11.25% | 6.91% | Upgrade
|
Effective Tax Rate | - | - | - | 31.23% | 38.13% | 49.70% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.